Alexis; Frank
Patent Applications and Registrations
Patent applications and USPTO patent grants for Alexis; Frank.The latest application filed is for "biodegradable waste remediation method and system".
Company Profile
2.24.28
- Alexis; Frank - Greenville SC
- Alexis; Frank - Brighton MA
Patent Activity
| Patent | Date |
|---|---|
| Biodegradable waste remediation method and system Grant 10,807,039 - Whitehead , et al. October 20, 2 | 2020-10-20 |
| Vaccine nanotechnology Grant 10,736,848 - Von Andrian , et al. A | 2020-08-11 |
| Biodegradable Waste Remediation Method and System App 20200164308 - WHITEHEAD; DANIEL ; et al. | 2020-05-28 |
| Vaccine Nanotechnology App 20200054559 - von Andrian; Ulrich H. ; et al. | 2020-02-20 |
| Drug Delivery Systems Using Fc Fragments App 20180311377 - Farokhzad; Omid C. ; et al. | 2018-11-01 |
| Receptor-targeted Nanoparticles For Enhanced Transcytosis Mediated Drug Delivery App 20180021455 - Pridgen; Eric M. ; et al. | 2018-01-25 |
| Vaccine nanotechnology Grant 9,539,210 - von Andrian , et al. January 10, 2 | 2017-01-10 |
| Receptor-targeted Nanoparticles For Enhanced Transcytosis Mediated Drug Delivery App 20170000899 - Pridgen; Eric M. ; et al. | 2017-01-05 |
| Vaccine nanotechnology Grant 9,526,702 - von Andrian , et al. December 27, 2 | 2016-12-27 |
| Vaccine nanotechnology Grant 9,474,717 - von Andrian , et al. October 25, 2 | 2016-10-25 |
| Adjuvant incorporation in immunoanotherapeutics Grant 9,439,859 - Alexis , et al. September 13, 2 | 2016-09-13 |
| Biodegradable Waste Remediation Method And System App 20160220952 - Whitehead; Daniel C. ; et al. | 2016-08-04 |
| Amphiphilic compound assisted nanoparticles for targeted delivery Grant 9,333,179 - Zhang , et al. May 10, 2 | 2016-05-10 |
| Targeting of antigen presenting cells with immunonanotherapeutics Grant 9,308,280 - Shi , et al. April 12, 2 | 2016-04-12 |
| Adjuvant incorporation in immunonanotherapeutics Grant 9,233,072 - Alexis , et al. January 12, 2 | 2016-01-12 |
| X-ray Excited Optical Materials and Methods for High Resolution Chemical Imaging App 20150362500 - Anker; Jeffrey ; et al. | 2015-12-17 |
| Biodegradable Polyester- And Poly(ester Amide) Based X-ray Imaging Agents App 20150290344 - Alexis; Frank ; et al. | 2015-10-15 |
| Nicotine immunonanotherapeutics Grant 8,932,595 - Iannacone , et al. January 13, 2 | 2015-01-13 |
| Immunonanotherapeutics that provide IGG humoral response without T-cell antigen Grant 8,906,381 - Iannacone , et al. December 9, 2 | 2014-12-09 |
| Vaccine Nanotechnology App 20140314865 - von Andrian; Ulrich H. ; et al. | 2014-10-23 |
| Adjuvant Incorporation in Immunonanotherapeutics App 20140127301 - Alexis; Frank ; et al. | 2014-05-08 |
| Targeting of Antigen Presenting Cells With Immunonanotherapeutics App 20140037736 - Shi; Jinjun ; et al. | 2014-02-06 |
| Adjuvant incorporation in immunonanotherapeutics Grant 8,637,028 - Alexis , et al. January 28, 2 | 2014-01-28 |
| Nicotine immunonanotherapeutics Grant 8,591,905 - von Andrian , et al. November 26, 2 | 2013-11-26 |
| Vaccine Nanotechnology App 20130287857 - von Andrian; Ulrich H. ; et al. | 2013-10-31 |
| Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,562,998 - Shi , et al. October 22, 2 | 2013-10-22 |
| Vaccine Nanotechnology App 20130236533 - von Andrian; Ulrich H. ; et al. | 2013-09-12 |
| Delivery System for Enhancing Drug Efficacy App 20130236504 - Alexis; Frank ; et al. | 2013-09-12 |
| Adjuvant Incorporation in Immunonanotherapeutics App 20130129790 - Alexis; Frank ; et al. | 2013-05-23 |
| Adjuvant incorporation in immunonanotherapeutics Grant 8,343,498 - Alexis , et al. January 1, 2 | 2013-01-01 |
| Targeting of antigen presenting cells with immunonanotherapeutics Grant 8,343,497 - Shi , et al. January 1, 2 | 2013-01-01 |
| Immunonanotherapeutics that provide IgG humoral response without T-cell antigen Grant 8,277,812 - Iannacone , et al. October 2, 2 | 2012-10-02 |
| IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN App 20120087890 - Iannacone; Matteo ; et al. | 2012-04-12 |
| Targeting Of Antigen Presenting Cells With Immunonanotherapeutics App 20110268804 - Shi; Jinjun ; et al. | 2011-11-03 |
| Adjuvant Incorporation In Immunonanotherapeutics App 20110268805 - Alexis; Frank ; et al. | 2011-11-03 |
| Drug Delivery Systems Using Fc Fragments App 20100303723 - Farokhzad; Omid C. ; et al. | 2010-12-02 |
| Vaccine Nanotechnology App 20100233251 - Von Andrian; Ulrich H. ; et al. | 2010-09-16 |
| Amphiphilic Compound Assisted Nanoparticles For Targeted Delivery App 20100203142 - ZHANG; Liangfang ; et al. | 2010-08-12 |
| Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen App 20100183727 - Iannacone; Matteo ; et al. | 2010-07-22 |
| Oligonucleotide Systems For Targeted Intracellular Delivery App 20100144845 - Farokhzad; Omid C. ; et al. | 2010-06-10 |
| Adjuvant Incorporation in Immunonanotherapeutics App 20100129439 - Alexis; Frank ; et al. | 2010-05-27 |
| Targeting of Antigen Presenting Cells with Immunonanotherapeutics App 20100129392 - Shi; Jinjun ; et al. | 2010-05-27 |
| Nicotine Immunonanotherapeutics App 20100092425 - von Andrian; Ulrich ; et al. | 2010-04-15 |
| Poly(amino Acid) Targeting Moieties App 20090074828 - Alexis; Frank ; et al. | 2009-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 